Advertisement

Ads Placeholder
Loading...

Prenetics Global Limited

PRE•NASDAQ
Healthcare
Medical - Diagnostics & Research
$19.68
$0.11(0.56%)
U.S. Market opens in 19h 46m

Prenetics Global Limited (PRE) Stock Overview

Explore Prenetics Global Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap276.6M
P/E Ratio-5.41
EPS (TTM)$-3.79
ROE-0.36%
Fundamental Analysis

AI Price Forecasts

1 Month$22.20
3 Months$25.42
1 Year Target$21.23

PRE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Prenetics Global Limited (PRE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $21.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.41 and a market capitalization of 276.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.56%
5-Day Change
-7.04%
1-Month Change
28.71%
3-Month Change
24.71%
6-Month Change
37.91%
Year-to-Date (YTD) Change
24.71%
1-Year Change
392.00%
3-Year Change
50.80%
5-Year Change
-82.73%
All-Time (Max) Change
-82.73%

Contact Information

https://www.prenetics.com
852 2210 9588
Unit 701-706, K11 Atelier King’s Road, Quarry Bay, NaN, NaN

Company Facts

2,850 Employees
IPO DateJul 16, 2021
CountryHK
Actively Trading

Frequently Asked Questions